Accelerate and expand access to innovative therapies for patients through exceptional delivery and expert support.
About NMDP BioTherapies
Accelerate and expand access to innovative therapies for patients through exceptional delivery and expert support.
We’ve provided successful cell therapy management and delivery for decades
Our team is part of NMDP℠ — an organization with 35+ years of experience delivering time-critical cell therapies to patients.
Our leaders knew that if we harnessed the experience and relationships we developed over decades, we could help cell and gene therapy companies bring emerging therapies to patients sooner. And with that knowledge, they formed NMDP BioTherapies.
Since 2016, we have partnered with cell and gene therapy companies to save more lives through cellular therapy.
We offer industry-leading solutions that scale at every step
NMDP BioTherapies has established services and infrastructure that make us unique from others in the industry. Some focus just on the cell and gene therapy supply chain. Others focus only on cell sourcing. Our services cover the full end-to-end spectrum that an allogeneic or autologous cell and gene therapy company needs.
In fact, our services go beyond vein to vein. We support any stage of the cell therapy supply chain—from prior to the point of patient identification all the way through patient outcomes data collection.
Advancing cell therapies for 35+ years
0
+
cell therapies facilitated
0
+ million
potential donors
0
+
ongoing studies and clinical trials
We’re driven by a common goal to save more lives through cellular therapy
Our NMDP BioTherapies leadership team brings a wealth of industry knowledge to support cell and gene therapy companies around the world.
Through their leadership, diverse skill set and proven track record, we help our partners advance new therapies.
Together, we can help all people get the cell or gene therapy they need.
Our shared commitment to advance next-generation cell and gene therapies unites us
We partner with companies across the industry to bring philanthropic goals to life
Philanthropy accelerates the NMDP mission to save lives through cell therapy by:
Growing and diversifying our registry of potential allogeneic donors
Providing financial and programmatic support to patients and caregivers
Fueling research to improve outcomes for patients regardless of their background
As you prepare to bring your therapy to market, we invite you to explore opportunities to grow brand awareness and engage patients, physicians, employees and the greater cell therapy community.
We look forward to learning about your goals, sharing strategies to achieve them and welcoming you to our community of supporters.
Nick Bayrakdarian, VP US Cell Therapy Operations
Our work together began years ago as NMDP helped us facilitate and execute our clinical trial program for omidubicel, and has continued through the FDA approval of our first commercial product, an allogeneic cell therapy donor source. The natural evolution has been to search out philanthropic and educational opportunities to partner with the NMDP Foundation to continue these important efforts. The alignment in values and goals makes our work together even more meaningful and important.
Together, we can make a difference as we work every day to save lives through transplant.”